Biotheus Inc. (CN)

https://www.biotheus.com

Biotheus Inc. is a clinical-stage biotech company dedicated to the discovery, development, and delivery of novel antibodies and cell therapies to address the unmet medical needs of patients with oncology and inflammatory diseases worldwide. Since its inception, Biotheus has established several innovative platforms for antibody discovery and a proprietary cell therapy that delivers T cell engagers into the tumor microenvironment to eradicate tumor cells. With an experienced development team, Biotheus has built a robust pipeline of ten programs at various stages of clinical development. *

	Start	2019-08-20 existent
	Industry	BIOTECH
	Industry 2	cancer immunotherapy (immuno-oncology, I-O)
	Person	Liu, Xiaolin (Biotheus 202307 CEO + Co-Founder)

	Street	Unit 10-B, Building 4, No.1, Keji 7th Road Tangjiawan Town, High-Tech Zone
	City	519080 Zhuhai, Guangdong
	Tel	+86-756-6998555
		Address record changed: 2023-07-23

Basic data	Employees	C: 51 to 100 (2019-08-20)

		* Document for »About Section«: Biotheus Inc.. (7/19/23). "Press Release: Biotheus Announces Strategic Research Collaboration and Worldwide License Agreement with BioNTech". Zhuhai.

		Record changed: 2024-01-07